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Abstract: New eating habits, actual trends in production and consumption have a health, 
environmental and social impact. The European Union is fighting diseases characteristic of 
a modern age, such as obesity, osteoporosis, cancer, diabetes, allergies and dental 
problems. Developed countries are also faced with problems relating to aging populations, 
high energy foods, and unbalanced diets. The potential of nutraceuticals/functional 
foods/food supplements in mitigating health problems, especially in the gastrointestinal 
(GI) tract, is discussed. Certain members of gut microflora (e.g., probiotic/protective 
strains) play a role in the host health due to its involvement in nutritional, immunologic 
and physiological functions. The potential mechanisms by which nutraceuticals/functional 
foods/food supplements may alter a host’s health are also highlighted in this paper. The 
establishment of novel functional cell models of the GI and analytical tools that allow tests 
in controlled experiments are highly desired for gut research. 
Keywords: nutraceutical; functional food; food supplement; intestinal health; probiotic; 
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1. Introduction 
Eating habits and trends in food production and consumption have health, environmental and social 
impacts. Diet has implications on gut health. Gut complications, such as ulcerative colitis, Crohn's 
disease, irritable bowel syndrome, and gluten therapy resistant celiac, result from overgrowth and 
imbalance of intestinal microbial flora, and are related to one’s diet. Notably, the gastrointestinal tract 
is sterile at birth; intestinal microflora develops after birth, with the colonization rate varying 
according to factors such as the mode of birth, infant nutrition, antibiotic use, diet and age. Gut health 
determines an individual’s overall health. The human gut has the following functions: (a) it breaks 
food down to nutrients, (b) it facilitates absorption of nutrients into the blood through intestinal walls, 
and (c) it prevents foreign and toxic molecules from entering the bloodstream. Gut malfunction, 
therefore, has a direct negative impact on human health. This review focuses on the role of functional 
foods, nutraceuticals, and food supplements in intestinal health.  
Consumption patterns vary significantly across Europe, from more southern healthy diets (rich in 
fruits and vegetables), to the northern ones (rich in animal fat and animal food products). Another 
striking difference is the fact that in northern European countries, eating is an individual affair, 
whereas in continental and southern countries consumers attach importance to the social dimension of 
food and sharing a meal [1]. These nutritional/consumption differences across Europe contribute 
greatly to the apparent differences in the health of populations on the continent. In spite of the fact that 
today’s consumers are increasingly attentive to food safety, quality and health-related issues, the 
population in the European Union (EU) is still fighting with the diseases of a modern age such as 
obesity, osteoporosis, cancer, diabetes, allergies, stress and dental problems.  
Furthermore, food additives, toxins and emerging food pathogens potentially present in fresh 
products and processed food present another threat, with their real effects being confounded by their 
adverse and synergistic effects. On the other hand, the increasingly aging populations in Europe 
require different foods for healthy aging [2]. Increased energy uptake, unbalanced diets, and highly 
processed foods used in fast food products are huge problems, which the EU [3] and other developed 
countries such as the United States of America [4-6] have to overcome. Nevertheless, economic crises 
and high food prices tend to favor unbalanced “cheap” food intake. Attributes such as educational 
inequalities also contribute to obesity in Europe [7]. However, the USA diet, notably, has the highest 
amount of calories for the lowest cost worldwide [8]. The USA also has the highest availability of 
large-scale agricultural commodities, and refined and processed food products.  
Based on the European Food Safety Authority (EFSA) Food-Based Dietary Guidelines, it is evident 
that in most EU member countries, the most frequent country-specific diet-related health problems are 
still cardiovascular diseases, overweight/obesity, dyslipidemia, hypertension, type 2 diabetes, 
osteoporosis and dental caries [9]. In 93% of EU countries, the EFSA reported that the average intake 
of total fat is above 30% of the energy intake, with the highest intake in Latvia, Lithuania and Slovenia 
[9]. Only in Italy the intake of saturated fat acids is below 10% [9]. However, overall, females tend to 
have lower dietary fat and higher carbohydrate intakes than males. Also notable is the fact that more 
females tend to consume fruits and vegetables within the recommended levels than males in Europe, 
based on data obtained in Central and Eastern Europe [10]. Moreover, it is a common observation in 
the EU that among the food groups (bread/cereals, rice/pasta/potatoes, vegetables, fruit, milk/dairy Nutrients 2010, 2                                       
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products, meat, fish, oils/fats, legumes and eggs), fruits and vegetables are not prioritized among 
consumers [11,12]. While consumers are aware of the link between eating and health, they expect 
visible implications of consumption of a particular product on health [13] and tend to acquire food 
based on convenience [14]. Recently, food manufacturers have embarked on a health criterion in the 
development of “functional foods”, the latter being defined as food products that have an added 
positive health benefit [15]. While some functional ingredient benefits may be perceived to enhance 
short-term well-being or performance ability, many such benefits concern the long-term mitigation of 
certain diseases [15]. Long term health benefits are generally invisible to the average consumer. 
Traditional foods are increasingly considered healthy and wholesome, and as a result, public interest in 
their nutritional and health impact has increased, as has their demand [15].  
2. Food and Health  
Food habits develop in early infancy. In fact, it is known that initial phases of life (intra-uterine 
period and the first year of life) are sensitive to nutritional factors [16]. Exclusive breastfeeding up to 
six months, with breastfeeding lasting up to two years or longer in combination with the introduction 
of balanced complementary feeding (CF), are emphasized by the World Health Organization (WHO) 
as important measures of public health, with effective impact on the reduction in the risk of developing 
chronic diseases. It is now known that children after the age of two years should be fed a nutritionally 
balanced diet similar to that of adults, particularly a diet low in sugar, salt and fat, and rich in complex 
carbohydrates, fruits and vegetables. Development of food habits is a complex process that may be 
influenced by such factors as region, religion, family structure and habits, income, prices, stress levels 
and technological advancements. Several epidemiologic studies over the last 50 years have clearly 
shown that diets dominated by fruits, vegetables and dietary fibers (plant based foods) prevent and 
reduce the risk of chronic diseases (e.g. cardiovascular diseases, obesity, diabetes) and promote sound 
human health. The generation of scientific research linking foods of plant origin and health worldwide 
has resulted in acknowledgement that plant bioactive compounds have anti-oxidant and other healthy 
properties [17,18].  
High
 dietary intake of fruits, vegetables and whole grains
 is strongly associated with reduced risk of 
developing chronic
 diseases, such as cancer and cardiovascular diseases (CVD), which
 are the highest 
causes of death in Europe, United States and in most
 industrialized countries [9,19]. It is estimated that 
one-third of all cancer deaths in industrialised countries could be avoided
 through appropriate dietary 
formulations. This suggests
 that dietary behavioral changes, such as increasing consumption
 of fruits, 
vegetables, and whole grains, and related changes in lifestyle,
 are practical strategies for significant 
reduction of the incidence
 of cancer [20]. There is a huge amount of scientific literature consistently, 
but not universally, linking consumption of diets rich in vegetables and fruits with reduced risk of 
cancer, particularly epithelial cancers of the alimentary and respiratory tracts [21]. Based on results 
from 206 human epidemiologic studies and 22 animal studies, similar effects of plant based diets are 
consistent for cancers of the stomach, esophagus, lung, oral cavity and pharynx, endometrium, 
pancreas, and colon [21]. The types of vegetables or fruit that most often appear to be protective 
against cancer are raw vegetables, followed by allium vegetables, carrots, green vegetables, 
cruciferous vegetables, and tomatoes [21]. Nutrients 2010, 2                                       
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In 1996 the American Dietetics Association produced a paper demonstrating protective effects of 
eating fruit and vegetables against several cancers.  
Cardiovascular diseases (CVD, including heart disease and stroke), represent the primary cause of 
death, with high negative impact on both human health and community social costs in Western 
countries. Cardiovascular diseases and tumors, together, contribute to more than 60 % of deaths in 
economically-developed countries [22]. In economically-developed countries, CVDs acquire a 
character of epidemic proportions, and surpass infectious diseases in mortality. Recent studies 
implicate reactive oxygen species (ROS) in the pathogenesis of both acute and chronic heart diseases 
as a result of cumulative oxidative stress [23]. In particular, oxidation of low density lipoproteins 
(LDL), the latter emanating from saturated, trans fats and meat products, has a key role in the 
pathogenesis of atherosclerosis and cardiovascular heart diseases through the initiation of the plaque 
formation process [23]. 
Important risk factors for CVD include obesity, high blood cholesterol level, high blood pressure 
and type 2 diabetes. The risk of CVD is increased not only by the consumption of poor diets, but also 
by lifestyle habits such as smoking and alcohol intake [23]. It has been shown that people consuming 
healthy diets, living active lifestyles, not smoking and not indulging in excessive alcohol consumption 
tend to have a reduced risk of CVD [24]. It is also known that diets leading to elevated serum total 
cholesterol, LDL-cholesterol, and triacylglycerol
  concentrations, while leading to reduced HDL-
cholesterol concentrations,
 lead to reduced risk of coronary artery disease. As a result, treatment of 
hypercholesterolemia has focused on increasing
 fecal excretion of cholesterol and bile acids, and 
reducing hepatic
 cholesterol synthesis through diet modification among the few optional strategies 
available [25,26]. 
Blood pressure control is important in the prevention of heart
 disease, kidney disease and stroke. 
Blood pressure is influenced by
 numerous factors including atherosclerosis, imbalances in the renin-
angiotensin system, and hyperinsulinemia, the latter increasing sodium retention in the body and 
speeding up atherosclerosis [27].
 Consequently, a general nutritional plan to minimize hypertension
 
risk includes attaining and maintaining a healthy body weight;
 consuming a diet rich in calcium, 
phosphorus, and magnesium; and consuming alcoholic beverages and sodium in moderation [28]. 
Obesity is a medical condition characterized by accumulation of excess body fat. As a condition, 
obesity is associated with reduced life expectancy and/or increased health problems [29]. Obesity is 
therefore not just a cosmetic problem [29]. Numerous studies indicate that higher levels of body fat are 
associated with an increased risk of many adverse health conditions. Weight loss is increasingly 
recognized as bringing major health benefits to overweight people and is linked with increases in life 
expectancy of people having obesity-related complications [30]. Overweight and obesity have 
increased over the past 20 years in many regions of the world, particularly the prevalence of obesity in 
childhood. Obesity is not only restricted to the developed world; it is also becoming a growing burden 
for the developing countries [31]. Data from the International Obesity Task Force (IOTF) [32] indicate 
that, worldwide, over 20 million children under the age of six are obese or overweight. Obesity is a 
multi factorial problem and its development is due to multiple interactions between genes and 
environment. There is a need to identify aspects of behavior that curtail excessive energy intake while 
enhancing energy expenditure. These include making appropriate dietary choices, embarking on good 
eating behavior, and having an active lifestyle [32]. Nutrients 2010, 2                                       
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Cancer development, a dynamic and long-term process, involves many complex factors with 
stepwise progression, ultimately leading to an uncontrolled spreading and growth of cancerous cells 
throughout the body, called metastasis. Epidemiological studies have provided convincing evidence 
that dietary factors can modify carcinogenesis. Laboratory research has further demonstrated that a 
number of bioactive dietary components or natural products have the ability to prevent cancer [17-18]. 
In addition, many food constituents with yet undefined nutritional benefits have been found to possess 
anti-mutagenic and anti-carcinogenic properties. Such promising research provides a strong support for 
the acceptance in the future of bioactive components of food as chemopreventative agents [33]. 
3. Functional Foods 
Functional foods are similar in appearance to conventional foods; the former being consumed as 
part of the normal diet. In contrast to conventional foods, functional foods, however, have 
demonstrated physiological benefits and can reduce the risk of chronic disease beyond basic nutritional 
functions, including maintenance of gut health [34]. When food is being cooked or prepared using 
"scientific intelligence" with or without knowledge of how or why it is being used, the food is called 
"functional food". Thus, functional food provides the body with the required amount of vitamins, fats, 
proteins, carbohydrates, etc., needed for its healthy survival [34]. 
4. Probiotics, Prebiotics and Synbiotics 
The human gut is populated by a wide array of bacterial species, the latter bearing important 
metabolic and immune functions, all leading to marked effects on the nutritional and health status of 
the host [35]. Probiotics, according to a consensus definition, are ‘living micro-organisms, which upon 
ingestion in certain numbers, exert health benefits beyond inherent basic nutrition’ [36,37], 
alternatively probiotics are loosely known as live microorganisms belonging to natural biota with low 
or no pathogenicity, but with functions of importance to the health and well being of the host [38,39]. 
Numerous probiotic microorganisms (e.g., Lactobacillus rhamnosus GG, Lactobacillus reuteri, 
bifidobacteria and certain strains of Lactobacillus casei, the Lactobacillus acidophilus-group, 
Escherichia coli strain Nissle 1917, certain enterococci, especially Enterococcus faecium SF68, and 
the probiotic yeast Saccharomyces boulardii) are used in probiotic food, particularly fermented milk 
products, or have been investigated with regard to their medicinal use. New genera and strains of 
probiotics are emerging; some with high health benefits as in Lactobacillus plantarum isolates 
(PCS20, PCS22, PCS25 and PCS26) from Slovenian cheese with high antimicrobial [40] and 
immunomodulatory [38] capabilities. Probiotics were originally used to influence human health 
through intestinal microbiota alterations. At present, probiotics and their effects on human health have 
been demonstrated both within different food matrices and as single or mixed microbial culture 
preparations. Furthermore, the health-promoting properties of probiotics are now known to be strain-
dependent [37-39]. An international expert group
 of the International Life Sciences Institute (ILSI) has 
evaluated the categorized and published evidence of functionality
 of different probiotics in four areas 
of (human) application, namely, (i)
 metabolism, (ii) chronic intestinal inflammatory and functional
 
disorders, (iii) infections, and (iv) allergy [41]. The ILSI report gives concrete examples demonstrating 
benefits and
 gaps, and guidelines and recommendations on the design of next generation of probiotic Nutrients 2010, 2                                       
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studies, with the aim to substantiate the current body of information on probiotic benefits. The effects 
of probiotics on human health are positive and well defined in diarrhoea treatment, however there are 
no clinical results regarding the dose of probiotics or duration of such treatments [42]. The results from 
clinical studies have not been conclusive in that the effects of probiotics on the host are dependent on 
probiotic strains, type of infection (acute or chronic gastrointestinal infections, immunological or 
inflammatory disease), different doses used and duration of treatment [42]. Probiotics have been 
shown to have applications in alleviating symptoms of allergies [43,44], cancer [45], AIDS [46], 
respiratory and urinary tract infections [47]. Furthermore, various findings suggest that probiotics have 
beneficial effects in alleviating symptoms associated with aging, fatigue, autism, and in reducing the 
risks of osteoporosis, obesity and possibly type 2 diabetes [48]. Advantages of probiotics for health 
can only be realized if proper probiotic strain or product selection, and dose guidelines of commercial 
production, are followed in human food or medicine [44,48]. 
The concentration of probiotics needed to obtain a clinical effect is often quoted as ≥10
6 colony 
forming units (cfu) per milliliter in the small bowel and ≥10
8 cfu/g in the colon. The dose for treatment 
of an acute illness by a particular probiotic agent may be lower or higher, in the order of 10-fold or 
100-fold or more in terms of cfu. In acute infectious diarrhoea, it seems that higher doses of probiotics 
given for short courses are more effective than lower doses. In chronic or immunological diseases 
(allergic, inflammatory and/or immune diseases), the effects of probiotics depend also on the 
interactions between the respective microorganisms and gut immune system, and duration of 
treatment. To evaluate the efficacy of probiotics it may be essential to identify specific target groups of 
individuals with more specific higher susceptibilities to the potential effects of probiotics. 
A prebiotic is "a selectively fermented ingredient, or a fiber that allows specific changes, both in 
the composition and/or activity of the gastrointestinal microflora, resultantly conferring benefits on the 
well being and health of host " [37,48]. Other, more specific effects of prebiotics on health are indirect, 
namely prevention of diarrhoea or obstipation, modulation of the metabolism of the intestinal flora, 
cancer prevention, effects on lipid metabolism, stimulation of mineral adsorption and 
immunomodulatory properties. Prebiotics form a group of diverse carbohydrate ingredients that is 
poorly understood in regard to their origin, fermentation profiles, and dosages required for health 
effects, although providing nutraceutical and nutritional value [48]. Today, only bifidogenic, non-
digestible oligosaccharides (particularly inulin, its hydrolysis product oligofructose, and 
(trans)galactooligosaccharides), fulfill all the criteria for prebiotic classification [37]. In the last few 
years, successful attempts have been reported to make infant formula more breast-milk-like by the 
addition of fructo- and (primarily) galactooligosaccharides.  
Probiotics and prebiotics share unique roles in human nutrition, largely centered on manipulation of 
populations or activities of the microbiota that colonize the human GI tract [48]. Regular consumption 
of probiotics or prebiotics has health implications that include enhanced immune function, improved 
colonic integrity, decreased incidence and duration of intestinal infections, down-regulated allergic 
response, and improved digestion and elimination [48].  
It is noteworthy that human subjects and their enteric microbiota have evolved together to reach a 
state of mutual tolerance. There is mounting evidence from both animal models and human studies to 
suggest that inflammatory bowel disease (IBD) is a result of a malfunction of this mutual relationship 
[49]. Probiotics and prebiotics, however, have been investigated in clinical trials as treatments for IBD, Nutrients 2010, 2                                       
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with conflicting results [49]. While there is general consensus about the value of probiotics and 
prebiotics, their influence on bowl health in terms of Crohn's disease is less convincing [49]. This may 
be attributed to variations in methodologies, differences in the range of probiotic, prebiotic and 
combination (synbiotic) treatments tested, and variability in test subjects used, such as different patient 
groups [49]. 
Synbiotics are synergistic combinations of pro- and prebiotics [37]. 
Mechanisms of probiotic actions  
While probiotics are gaining significant interest as alternatives for antibiotics or anti-inflammatory 
drugs, their mode of action is poorly understood [50]. Probiotics may act by modulating the host's 
immune system, affecting other microorganisms directly or acting on microbial products, host products 
or food components [50]. The effectiveness of a probiotic depends on its metabolic properties, the set 
of molecules presented at its surface, the components it secretes, and the integral parts of the 
microorganism such as its DNA or peptidoglycan [50].  
Imbalance of Intestinal Microbial Flora  
Modern lifestyles tend to impose stress on systems genetically adapted over millions of years. The 
consumption of food containing microorganisms has dramatically reduced, and as a consequence, the 
developing mucosal immune systems are faced with different microflora, particularly fewer pathogens 
than paleolithic man. Increases in observed incidence and severity of allergies and conditions such as 
IBD in the Western world have been linked with increases in standards of hygiene and sanitation, 
which have occurred concomitantly with decreases in the number and range of infectious challenges 
encountered by the growing and developing host. This lack of immune education impairs the 
development of the immune system and allows the host to over-react to non-pathogenic antigen-
containing commensal flora, resulting in inflammatory damage, allergy and/or autoimmunity [51]. To 
combat these trends directly, the World Health Organisation currently advocates the implementation of 
alternative disease control strategies, such as exploiting the prophylactic and therapeutic potential of 
probiotic bacteria [52]. Most of these probiotic microorganisms, isolated from such sources as faeces 
of healthy individuals, are safe for human consumption and are available over the counter. Because of 
continued scepticism of such products, European Union funded research groups including medical, 
scientific and industrial interests, have agreed on criteria for selection and assessment of probiotics. 
5. Nutraceuticals  
The term "nutraceutical" was coined from "nutrition" and "pharmaceutical" in 1989 by Stephen 
DeFelice, MD, founder and chairman of the Foundation for Innovation in Medicine (FIM), Cranford, 
NJ [53]. DeFelice proceeded to define nutraceutical as, "a food (or part of a food) that provides 
medical or health benefits, including the prevention and/or treatment of a disease" [53]. When 
functional food aids in the prevention and/or treatment of disease(s) and/or disorder(s) other than 
anaemia, it is called a nutraceutical [54]. It should be noted that the term nutraceutical, as commonly 
used in marketing, has no regulatory definition [55]. Thus, nutraceuticals differ from dietary 
supplements in the following aspects: (1) nutraceuticals must not only supplement the diet but should Nutrients 2010, 2                                       
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also aid in the prevention and/or treatment of disease and/or disorder; and (2) nutraceuticals are used as 
conventional foods or as sole items of a meal or diet [56]. Dietary components play beneficial roles 
beyond basic nutrition, leading to the development of the functional food concept and nutraceuticals 
[35]. A functional food for one consumer can act as a nutraceutical for another consumer. Examples of 
nutraceuticals include fortified dairy products (e.g., milk) and citrus fruits (e.g., orange juice) [56]. 
Several naturally derived food substances have been studied in cancer therapies. Vitamin E, 
selenium, vitamin D, green tea, soy, and lycopene are examples of nutraceuticals widely studied in 
human health [53]. While many of these 'natural' compounds have been found to have high therapeutic 
potential; future studies should include well-designed clinical trials assessing combinations of these 
compounds to realize possible synergies they bring into human health.  
Polyunsaturated fatty acids (PUFAs) (which include the omega-3 and omega-6 fatty acids) and 
phytochemicals also play an important role as healthy dietary bioactive compounds [35]. A balanced 
PUFA composition of food influences diverse aspects of immunity and metabolism [35]. Moreover, 
interactions between PUFAs and components of the gut microbiota may also influence their biological 
roles. Phytochemicals (bioactive non-nutrient plant compounds), have raised interest in human 
nutrition because of their potential effects as antioxidants, antiestrogenics, anti-inflammatory, 
immunomodulatory, and anticarcinogenics [17,35]. Gut microbiota can, for example, transform and 
influence the bioavailability and effects of polyphenols [35]. Phytochemicals and their metabolic 
products may also inhibit pathogenic bacteria [17,35] while stimulate the growth of beneficial bacteria, 
exerting prebiotic-like effects [34]. Interactions between functional food components, such as 
prebiotics, probiotics, phytochemicals, and intestinal microbiota, have consequences on human   
health [35]. 
6. Food Supplements 
According to the US Dietary Supplement Health and Education Act (DSHEA) of 1994, the term 
"dietary supplement" can be defined using several criteria; namely (a) a product (other than tobacco) 
that is intended to supplement the diet that bears or contains one or more of the following dietary 
ingredients: a vitamin, a mineral, an herb or other botanical, an amino acid, a dietary substance for use 
by man to supplement the diet by increasing the total daily intake, or a concentrate, metabolite, 
constituent, extract, or combinations of these ingredients [55], (b) a product intended for ingestion in 
pill, capsule, tablet, or liquid form, (c) a product not represented for use as a conventional food or as 
the sole item of a meal or diet, (d) anything labeled as a "dietary supplement", and (e) products such as 
a newly approved drug, certified antibiotic, or licensed biologic that was marketed as a dietary 
supplement or food before approval, certification, or license (unless if this provision is waived by an 
authority such as Secretary of Health and Human Services, as in USA) [56]. 
Under the DSHEA (1994), the manufacturer of a dietary supplement is responsible for ensuring that 
the dietary supplement is safe before it is marketed [57]. It is also binding to the manufacturers that 
they make sure that product label information is truthful and not misleading [57]. 
Many European countries have adopted the highly restrictive CODEX standards for dietary 
supplements, which eliminate the consumer’s ability to purchase dietary supplements in therapeutic or 
meaningful preventive dosages. Codex Alimentarius (Latin for "Food Code") is the United Nation’s 
proposed set of international guidelines for nutritional supplements, food handling, production, and Nutrients 2010, 2                                       
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trade which is gradually being ratified in countries around the world, starting in the EU [58].  In 
comparison to most other industrialized countries, there is virtually no restriction on the type or 
strength of nutritional supplements that can be purchased in the United States [58]. The only 
significant limitation on the sale of supplements is that disease and cure related claims cannot be made 
by supplement manufacturers without USA Food and Drug Agency (FDA) approval. And the FDA has 
approved only a few disease related claims for supplements [58]. 
Questions can arise whether a nutrient used as part of a treatment for a defined disease can be 
considered a drug, whereas the same nutrient is used to enhance health (reduce the risk of disease), can 
be considered a functional food or dietary supplement? This overlap shows interlinks that exist 
between functional foods and medicines. 
Mounting evidence supports the observation that functional foods containing physiologically active 
components, either from plant or animal sources, may enhance health [59]. Clearly, all foods are 
functional, as they provide taste, aroma, or nutritive value [59]. There has been an explosion of 
consumer interest in the health enhancing role of specific foods or physiologically-active food 
components, so-called functional foods [59]. It should be stressed, however, that functional foods are 
not a magic bullet or universal panacea for poor health habits [59]. There are no "good" or "bad" foods, 
but there are good or bad diets [59].  
7. The Intestinal Health  
Proper functioning of the digestive tract, with both its chemical and muscular activity, is essential to 
health. Digestive disorders are on the increase. About 38 million Americans suffer from a variety of 
digestive problems such as gastroesophageal reflux disease (GERD), irritable bowel syndrome, celiac 
disease, food allergies, diverticulitis, ulcerative colitis, and Crohn’s disease [60]. Approximately 25 
million Americans have daily heartburn, and it is estimated that 20% of the adult population have 
irritable bowel syndrome. Celiac disease, once considered rare, is now thought to affect 1 in 133 
people, and food allergies have increased alarmingly [60]. 
8. The Gastrointestinal (GI) Tract as an Ecosystem  
Co-evolution led to a symbiotic relationship between eukaryotes and prokaryotes with the 
development of sophisticated by-directional signaling systems of mucosal epithelia and lymphocytes 
in the intestinal tract [51]. It is estimated that over 400 species of bacteria, separated into two broad 
categories, namely beneficial (e.g., Bifidobacterium and Lactobacillus) and those considered 
detrimental (e.g., Enterobacteriaceae and Clostridium spp.) inhabit the human gastrointestinal tract. 
Bacterial end products of fermentation are essential mucosal nutrients including amino acids (arginine, 
cysteine and glutamine) and short chain fatty acids (SCFA: acetate, propionate and butyrate) [51]. 
These SCFAs serve as an energy source for the host, providing 10–30% of basal metabolic 
requirements including energy for liver cells, colonocytes and peripheral tissues with only about 5% 
excreted in the feces [51]. Besides fermentation, the metabolic products of the microflora includes 
vitamins K and B complex, secondary bile acid production, neutralization of dietary carcinogens such 
as nitrosamines, and conversion to active metabolites of some prodrugs. The indigenous intestinal 
(autochthonous) microbiota act as a further barrier against any transient (allochthonous) potential Nutrients 2010, 2                                       
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pathogens by competing for nutrients and mucosal adherence and by production of antigens 
(bacteriocins), which are active against pathogens. Furthermore, it has been clearly established that the 
gastrointestinal flora are essential for mucosal protection and immune education as it has been 
described as the most adaptable and renewable metabolic organ of the body. The composition and 
activities of gastrointestinal flora affect both intestinal and systemic physiology. The complex 
gastrointestinal microbial load is required for normal development and homeostasis of the humoral and 
cellular immune system. It is the interaction between the mucosal immune system and the enteric 
microflora which maintains the physiologically normal state or activation of immune organ, the latter 
resulting in secretion of antibodies against harmful antigens (pathogenic microorganisms) [51].  
9. Application of Intestinal Cell Models  
Functional cell/co-culture models involve growth of cell lines in co-culture, either in direct contact 
with each other on the membrane or indirectly where one cell line is cultured on the apical side of a 
membrane and the other cell line on either the underside of the membrane (basolateral) or on the 
surface of the plastic feeder or receiver trays in multi-well cell plates [61-64]. Use of cells in co-culture 
systems mimics the natural existence of such cells in an organism, so that direct effects on cells, 
tissues or organs of chemicals, microorganisms and their products and so forth, can be tested in situ. 
The direct mixing of different cell types in culture is otherwise normally avoided in co-culture 
systems, allowing scientists to model such interactions in vivo. Functional/co-culture cell models are 
increasingly gaining recognition in science, as they mimic normal organ, tissue and physiological 
organization in human organism.  
In a co-culture system, two or more cell types brought together in the same culture environment 
very likely interact and communicate [65]. Co-culture has proved to be a powerful in vitro tool in 
unravelling the importance of cellular interactions during normal physiology, homeostasis, repair and 
regeneration [65]. 
Figure 1. Co-culture set up system. 
 
 
Co-culture cell systems have been used in a variety of applications such studies on disease 
pathogenesis, for example Crohn’s disease [63] drug testing [64], study of xenobiotic kinetics [66], 
studies on cancer progression [67], to name a few examples.
 The advantages
 of studying effects of 
different substances in vitro on cell lines include: (i) the ability
 to manipulate cells in a defined 
environment and to retrieve
 and study specific cell types; (ii) ability to identify novel growth
 or 
inhibitory paracrine factors involved in regulation of growth; (iii) cell behavior is easier to reproduce Nutrients 2010, 2                                       
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in these in situ models than in vivo; (iv)  they provide
 a physiological basis for future studies of 
molecular and genetic
 mechanisms of disease; and (v) they allow dissection of mechanisms
 of cell-cell 
and cell-matrix interactions involved
 in human disease, while avoiding extrapolation of
 data from 
studies using other species. Co-culture systems are therefore important developments with novel 
medical applications and resulting in reduced testing of substances on living animals.  
Co-culture systems and studies of interactions between probiotic bacteria and intestinal epithelium.  
Recently Gradisnik et al., (2006) [68] reported establishment of a pig functional cell model 
involving two pig intestinal epithelial cell lines (PSI and CLAB) and macrophages from pig peripheral 
blood (PoMac), with possible applications in both human and animal studies. This model was 
developed in sight of the substantial lack of good intestinal cell culture models. It was noted that pig 
cell lines represented better animal models than rodents in human research. Recently Nissen et al., 
(2009) [39] have reported use of the pig functional cell model described by Gradisnik et al.  [68] in 
studies of interactions between intestinal epithelium, macrophages and probiotic bacteria. Such a 
model has been found to give novel effects in such interactions. Current efforts are centred on 
development of human co-culture model systems, including use of three-dimensional co-culture 
systems for use in studying gut health, and development of nutraceuticals or functional ingredients of 
foods with useful protective effects on the GI tract.   
10. Conclusion 
Overall, this paper discusses nutraceuticals/functional foods/food supplements (broadly including 
probotics, prebiotics, synbioitcs, phytochemicals etc.), especially the need for consuming appropriate 
diets, health issues surrounding failure to adhere to the known healthy eating models, development of 
new nutraceuticals/functional foods/food supplements with novel health benefits, elucidation 
mechanisms of action of these products, development of study systems such as in-vitro co-culture cell 
models. Appropriate diet culminates in a healthy, properly functioning GI tract, resulting in attainment 
of proper human physiology, hence healthy living; otherwise the opposite becomes true. Modeling 
new eating habits using the existing knowledge is needed for the eventual ideal of ‘health for   
all’ vision.  
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